Sonic Augmentation Technology™ (SAT) improves self-reported well-being and increases salivary oxytocin.
Background
Prevalent mental health conditions like anxiety and depression are often linked to dysregulation of the autonomic nervous system and impaired interoception. While current treatments exist, there's a need for accessible, non-invasive alternatives. The Polyvagal theory highlights the vagus nerve's role in regulating physiological and emotional states, suggesting auditory interventions could modulate autonomic function. This study addresses the gap for low-cost methods to support autonomic regulation and enhance well-being, particularly for individuals with heightened autonomic reactivity.
Study Design
This feasibility study examined Sonic Augmentation Technology™ (SAT), a novel auditory probe incorporating continuously varying acoustic features modeled on autonomic regulation patterns. The study collected data from 113 participants across two samples: 72 virtually and 41 in-person. Participants completed self-report measures assessing biobehavioral state, autonomic reactivity, and psychiatric symptoms (anxiety and depression) both pre- and post-SAT exposure. For the 41 in-person participants, salivary oxytocin (pg/mL) was measured via enzyme immunoassay before and after SAT to assess physiological changes.
Results
Following exposure to SAT, participants reported significant improvements in their total biobehavioral state. These improvements extended to both the low and high arousal subscales of biobehavioral state. Greater decreases in the low arousal subscale were observed in the participants with increased anxiety.
Participants scoring above the cutoff for autonomic reactivity, anxiety, and depression reported greater increases in total biobehavioral state and more pronounced decreases in the high arousal subscale. Furthermore, the subset of 41 participants from whom salivary samples were collected exhibited notable increases in salivary oxytocin levels post-SAT, suggesting a physiological mechanism underlying the reported improvements in well-being.
Key Findings
- SAT significantly improved total self-reported biobehavioral state.
- Participants with higher baseline anxiety/depression showed greater improvements in well-being.
- SAT led to significant increases in salivary oxytocin levels.
- Individuals with increased anxiety experienced greater decreases in low arousal.
Why It Matters
Sonic Augmentation Technology™ (SAT) offers a promising, non-invasive, and low-cost approach to enhance well-being and autonomic regulation, particularly for individuals struggling with anxiety and depression. This could provide an accessible adjunct or alternative to existing therapies, potentially broadening the reach of mental health support. The observed increase in oxytocin suggests a tangible physiological pathway, moving beyond purely subjective reports. While further research is needed, this feasibility study lays groundwork for developing practical, auditory-based protocols that could be easily integrated into daily routines for stress reduction and emotional balance.